- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04275037
The Hypotensive Effects of Home-Based Isometric Handgrip Training in Older Adults With Pre-Hypertension and Hypertension - The HoldAge Trial
May 19, 2023 updated by: Alberto Alves, University Institute of Maia
New data suggests that isometric handgrip training (IHT) might become a novel tool in the treatment of hypertension.
The main purpose of this research project is to evaluate the effects of home-based IHT on ambulatory blood pressure in older adults with pre-hypertension and hypertension.
Eighty-four older adults with pre-hypertension and hypertension will be randomly distributed to one of three groups: home-based IHT, home-based aerobic exercise training (AET), or attention-control group (CON).
Each intervention will have a total duration of 8 weeks.
At baseline and after completing the intervention, patients will undergo the following evaluations: 24-hour ambulatory blood pressure, cardiorespiratory fitness, endothelial function, damage and repair, arterial stiffness, inflammatory biomarkers, autonomic function, physical activity levels, dietary intake and quality of life.
A qualitative analysis will also be applied to enhance the understanding of the efficacy of this intervention from the patient's perspective.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
84
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Aveiro, Portugal, 3810-193
- University of Aveiro
-
Aveiro, Portugal, 3810-096
- Hospital Infante D. Pedro, Centro Hospitalar do Baixo Vouga, Aveiro, Portugal
-
Aveiro, Portugal, 3810-193
- Institute of Biomedicine
-
Guimarães, Portugal, 4765-546
- Unidade de Saúde Familiar Serzedelo
-
Porto, Portugal, 4200-450
- CINTESIS, Faculty of Medicine, Porto, Portugal
-
Vila Real, Portugal, 5001-801
- Reserach Center in Sports Sciences, Health Sciences and Human Development
-
-
Aveiro
-
Santa Joana, Aveiro, Aveiro, Portugal, 3810-164
- Unidade de Saúde Familiar de Santa Joana
-
-
Porto
-
Maia, Porto, Portugal, 4475-690
- University Institute of Maia
-
Matosinhos, Porto, Portugal, 4450-113
- Hypertension Unit, Hospital Pedro Hispano, ULS, Matosinhos, Portugal
-
-
-
-
Connecticut
-
Storrs, Connecticut, United States, 06269
- University of Connecticut
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
-
Exclusion Criteria:
- Secondary Hypertension
- Target Organ Damage
- Coronary Artery Disease
- Heart Failure
- Any Previous Cardiovascular Event
- Peripheral Artery Disease
- Renal Failure
- Chronic Obstructive Pulmonary Disease
- Insulin Dependent Diabetes
- Change of Antihypertensive Medication in the Past 4 Weeks Before Inclusion in the Study
- Smokers
- Those Participating in Regular Physical Activity
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Isometric Handgrip Training
The 8-week exercise program will include three sessions of isometric handgrip training per week
|
The 8-week exercise program will include three sessions of isometric handgrip training per week
|
|
Active Comparator: Aerobic Exercise Training
The 8-week exercise program will include three sessions of aerobic exercise per week
|
The 8-week exercise program will include three sessions of aerobic exercise per week
|
|
No Intervention: Control Group
The control group will receive usual medical care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
24h ambulatory blood pressure
Time Frame: Change from baseline to 2 months
|
Change from baseline to 2 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Arterial Stiffness
Time Frame: Change from baseline to 2 months
|
Assessed by application tonometry using carotid-femoral pulse wave velocity as the gold-standard measure
|
Change from baseline to 2 months
|
|
Endothelial function
Time Frame: Change from baseline to 2 months
|
Assessed by brachial artery dilation to endothelial-dependent stimuli using an ultrasound, according to the recommendations
|
Change from baseline to 2 months
|
|
Inflamamtion
Time Frame: Change from baseline to 2 months
|
Plasma levels of inflammatory and anti-inflammatory biomarkers including C-reactive protein, Interleukin-10, total nitric oxide and nitrate/nitrite, endothelial Nitric Oxide Synthase
|
Change from baseline to 2 months
|
|
Endothelial cell repair/damage
Time Frame: Change from baseline to 2 months
|
Assessed by the circulating number of endothelial progenitor cells and circulating endothelial cells in a peripheral blood by flow cytometry.
|
Change from baseline to 2 months
|
|
Health-related quality of life
Time Frame: Change from baseline to 2 months
|
Assessed by the Short-Form 36
|
Change from baseline to 2 months
|
|
Aerobic fitness
Time Frame: Change from baseline to 2 months
|
Assessed by Chester Step Test
|
Change from baseline to 2 months
|
|
Weekly physical activity sleep quality
Time Frame: Change from baseline to 2 months
|
Measured in seven consecutive days by accelerometry
|
Change from baseline to 2 months
|
|
Intervention quality
Time Frame: two weeks after the intervention
|
Assessed by focus group interviews using semi-structured guide with the participants of the experimental groups
|
two weeks after the intervention
|
|
Sleep quality
Time Frame: Change from baseline to 2 months
|
Measured in seven consecutive days by accelerometry
|
Change from baseline to 2 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Alberto J Alves, PhD, CIDESD, University Institute of Maia, Maia, Portugal
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 12, 2021
Primary Completion (Actual)
January 30, 2023
Study Completion (Actual)
January 30, 2023
Study Registration Dates
First Submitted
February 10, 2020
First Submitted That Met QC Criteria
February 14, 2020
First Posted (Actual)
February 19, 2020
Study Record Updates
Last Update Posted (Actual)
May 22, 2023
Last Update Submitted That Met QC Criteria
May 19, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- POCI-01-0145-FEDER-030646
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
Clinical Trials on Isometric Handgrip Training
-
University of Massachusetts, BostonCompleted
-
University of PernambucoCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Fundação de Amparo... and other collaboratorsCompleted
-
Emory UniversityAmerican Heart AssociationRecruiting
-
University of PernambucoFundação de Amparo à Pesquisa do Estado de São PauloCompletedPeripheral Artery DiseaseBrazil
-
KU LeuvenResearch Foundation FlandersCompleted
-
Riphah International UniversityCompletedChronic Obstructive Pulmonary DiseasePakistan
-
University of Texas at AustinCompleted
-
Universidade Federal de Santa CatarinaConselho Nacional de Desenvolvimento Científico e TecnológicoRecruiting
-
University of NottinghamThe Royal College of Surgeons of England; The Dunhill Medical TrustUnknownHypertension | Perioperative HypertensionUnited Kingdom
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil